Literature DB >> 869513

Relationship between chemical structure and adjuvant activity of some synthetic analogues of N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP).

F Audibert, L Chedid, P Lefrancier, J Choay, E Lederer.   

Abstract

Synthetic N-acetyl-muramyl-L-alanyl-D-isoglutamine, hereafter referred to as muramyl dipeptide or MDP, represents the minimal structure which can replace mycobacterial cells in Freund's complete adjuvant. This synthetic adjuvant can also enhance the humoral antibody response when administered to mice with an antigen in water by various routes including the oral route. The present paper reports some new results concerning the relationship between the structure and the adjuvant activity of MDP. Synthetic analogues of MDP were tested either in a water-in-oil emulsion in guinea-pigs or in saline in mice. The chemical modifications concerned essentially the D-glutamyl residue. The results obtained confirm the importance of maintaining the intact structure of the D-Glu residue and show that adjuvant activity can be abolished by certain modifications at the level of both carboxyl functions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 869513

Source DB:  PubMed          Journal:  Ann Immunol (Paris)        ISSN: 0300-4910


  12 in total

1.  Failure of synthetic muramyl dipeptide to increase antibacterial resistance.

Authors:  H Finger; C H Wirsing von König
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

Review 2.  Muramyl peptides. Chemical structure, biological activity and mechanism of action.

Authors:  A Adam; J F Petit; P Lefrancier; E Lederer
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

3.  Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.

Authors:  I Azuma; H Okumura; I Saiki; M Kiso; A Hasegawa; Y Tanio; Y Yamamura
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

4.  Adjuvant activity of 6-amino-6-deoxy-muramyldipeptides and their acylamino derivatives on the induction of delayed hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.

Authors:  I Azuma; H Okumura; I Saiki; Y Tanio; M Kiso; A Hasegawa; Y Yamamura
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

5.  Release of soluble peptidoglycan from growing gonococci: hexaminidase and amidase activities.

Authors:  R S Rosenthal
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

6.  Structure specificity of some immunoadjuvant synthetic glycopeptides.

Authors:  K Masek; M Zaoral; J Jezek; V Krchnák
Journal:  Experientia       Date:  1979-10-15

7.  Screening for potential adjuvants administered by the pulmonary route for tuberculosis vaccines.

Authors:  Chenchen Wang; Pavan Muttil; Dongmei Lu; Adela Ayulia Beltran-Torres; Lucila Garcia-Contreras; Anthony J Hickey
Journal:  AAPS J       Date:  2009-03-10       Impact factor: 4.009

8.  Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil.

Authors:  C Carelli; F Audibert; L Chedid
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

9.  Adjuvant activity of N-acetyl muramyl dipeptides for the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.

Authors:  I Azuma; K I Kamisango; I Saiki; Y Tanio; S Kobayashi; Y Yamamura
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

10.  Colony-stimulating activity induced by synthetic muramyl peptides: variation with chemical structure and association with anti-infectious activity.

Authors:  A Galelli; P Lefrancier; L Chedid
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.